UK clinics prescribe medical cannabis, patients pay
SkimNews Take
Legalisation without NHS prescribing pathways effectively turns the policy into a private-pay system, so the legislative "victory" delivered medicine to those who can afford it rather than to the patients the law nominally served.
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Hannah Deacon turned to medical cannabis after conventional NHS treatments failed to control her son Alfie's seizures, and she first searched for “natural remedies for epilepsy” online in 2017.
- UK law previously classified medicinal cannabis as a Schedule 1 substance, the strictest drug category, but recent policy changes now permit private clinics to prescribe it.
- Private clinics prescribing medical cannabis now number more than 30 across the UK, with locations in Sunderland, Leicester, and London.
- Advertising for medical cannabis appears on the London Underground and billboards, and celebrities such as Claudia Winkleman and Anthony Joshua have partnered with CBD brands.
- NHS still offers limited access to medical cannabis, meaning most patients must pay privately for treatment.
- William O’Shaughnessy conducted early 19th‑century trials showing cannabis could treat convulsions, but the 1928 Dangerous Drugs Act later prohibited cannabis in the UK.
- Alfie was diagnosed at age five with PCDH19, a rare form of epilepsy, after years of seizures and ineffective medication.
Why it matters: Patients gain legal access to cannabis through a growing network of private clinics, but the NHS’s continued restriction forces families to shoulder high out‑of‑pocket costs, highlighting a gap between policy liberalisation and public health provision; the disparity benefits private providers while leaving many families financially strained.
